Stock CELATOR PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Celator Pharmaceuticals Inc

Equities

US15089R1023

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Celator Pharmaceuticals Inc
2016 Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal RE
2016 Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ RE

Managers

Managers TitleAgeSince
Arthur C. Louie CTO
 Chief Tech/Sci/R&D Officer - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 42,470,256 39,489,025 ( 92.98 %) 0 92.98 %

Company contact information

Celator Pharmaceuticals, Inc.

200 PrincetonSouth Corporate Center Suite 180

08628, Ewing

+

http://www.celatorpharma.com
address Celator Pharmaceuticals Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Celator Pharmaceuticals Inc